Andras Szasz

This definitive volume offers a robust and comprehensive examination of Oncothermia (modulated electro-hyperthermia, mEHT), bridging the foundational biophysics with cutting-edge clinical practice in the era of immunotherapy. Recognizing the generally limited biophysical expertise among practicing physicians, the book is intentionally structured as a detailed handbook that prioritizes theoretical grounding to ensure the accurate interpretation of complex data. Part II: Experimental Evidence and Clinical Outcomes provide the necessary empirical proof. The section synthesizes an extensive body of experimental and research evidence, derived from in silico modeling, phantom studies, and comprehensive in vitro and in vivo research, including specialized immunological investigations. This evidence base culminates in a systematic review of clinical outcomes, clearly categorized and presented according to the specific localization of the malignant tumor.

This definitive volume offers a robust and comprehensive examination of Oncothermia (modulated electro-hyperthermia, mEHT), bridging the foundational biophysics with cutting-edge clinical practice in the era of immunotherapy. Recognizing the generally limited biophysical expertise among practicing physicians, the book is intentionally structured as a detailed handbook that prioritizes theoretical grounding to ensure the accurate interpretation of complex data. Part I: Challenges, Technical Solutions, and Immune Interplay meticulously establish the theoretical landscape. It begins by defining the key biophysical and technical challenges currently facing the clinical application of Oncothermia. This critical analysis is immediately followed by a systematic presentation of solutions, encompassing detailed discussions on technical implementation (thermal and non-thermal effects, selective action mechanisms) and the profound biological interplay with the immune system.

Oncothermia is the next generation medical innovation that delivers selective, controlled and deep energy for cancer treatment. The basic principles for oncothermia stem from oncological hyperthermia, the oldest approach to treating cancer. Nevertheless, hyperthermia has been wrought with significant controversy, mostly stemming from shortcomings of controlled energy delivery. Oncothermia has been able to overcome these insufficiencies and prove to be a controlled, safe and efficacious treatment option. This book is the first attempt to elucidate the theory and practice of oncothermia, based on rigorous mathematical and biophysical analysis, not centered on the temperature increase. It is supported by numerous in-vitro and in-vivo findings and twenty years of clinical experience. This book will help scientists, researchers and medical practitioners in understanding the scientific and conceptual underpinnings of oncothermia and will add another valuable tool in the fight against cancer. Professor Andras Szasz is the inventor of oncothermia and the Head of St Istvan University's Biotechnics Department in Hungary. He has published over 300 papers and lectured at various universities around the world. Dr. Oliver Szasz is the managing director of Oncotherm, the global manufacturer and distributor of medical devices for cancer treatment used in Europe & Asia since the late 1980s. Dr. Nora Szasz is currently a management consultant in healthcare for McKinsey & Co.

Oncothermia is the next generation medical innovation that delivers selective, controlled and deep energy for cancer treatment. The basic principles for oncothermia stem from oncological hyperthermia, the oldest approach to treating cancer. Nevertheless, hyperthermia has been wrought with significant controversy, mostly stemming from shortcomings of controlled energy delivery. Oncothermia has been able to overcome these insufficiencies and prove to be a controlled, safe and efficacious treatment option. This book is the first attempt to elucidate the theory and practice of oncothermia, based on rigorous mathematical and biophysical analysis, not centered on the temperature increase. It is supported by numerous in-vitro and in-vivo findings and twenty years of clinical experience. This book will help scientists, researchers and medical practitioners in understanding the scientific and conceptual underpinnings of oncothermia and will add another valuable tool in the fight against cancer. Professor Andras Szasz is the inventor of oncothermia and the Head of St Istvan University's Biotechnics Department in Hungary. He has published over 300 papers and lectured at various universities around the world. Dr. Oliver Szasz is the managing director of Oncotherm, the global manufacturer and distributor of medical devices for cancer treatment used in Europe & Asia since the late 1980s. Dr. Nora Szasz is currently a management consultant in healthcare for McKinsey & Co.